Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19
Amrita Chatterjee1, Rajdeep Saha1, Arpita Mishra2
1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India.
Abstract:
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has enveloped the world into an unprecedented pandemic since 2019. Significant damage to multiple organs, such as the lungs and heart, has been extensively reported. Cardiovascular injury by ACE2 downregulation, hypoxia-induced myocardial injury, and systemic inflammatory responses complicate the disease. This virus causes multisystem inflammatory syndrome in children with similar symptoms to adult SARS-CoV-2-induced myocarditis. While several treatment strategies and immunization programs have been implemented to control the menace of this disease, the risk of long-term cardiovascular damage associated with the disease has not been adequately assessed. In this review, we surveyed and summarized all the available information on the effects of COVID-19 on cardiovascular health as well as comorbidities. We also examined several case reports on post-immunization cardiovascular complications.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause significant cardiovascular damage, including myocarditis. This review assesses COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread organ damage, particularly affecting the cardiovascular system.
- Mechanisms of cardiovascular injury include ACE2 downregulation, hypoxia, and systemic inflammation, complicating COVID-19 disease and leading to conditions like multisystem inflammatory syndrome.
- While treatments and vaccines exist, the long-term cardiovascular consequences of COVID-19 remain insufficiently understood.
Purpose of the Study:
- To comprehensively review and synthesize existing data on the cardiovascular effects of COVID-19.
- To examine the impact of COVID-19 on patients with pre-existing cardiovascular comorbidities.
- To investigate reported cardiovascular complications following SARS-CoV-2 vaccination.
Main Methods:
- Systematic survey and summarization of available literature on COVID-19 and cardiovascular health.
- Analysis of case reports detailing post-immunization cardiovascular events.
- Review of studies focusing on COVID-19's impact on cardiac function and inflammatory markers.
Main Results:
- COVID-19 is associated with diverse cardiovascular complications, including myocardial injury and inflammatory syndromes.
- Pre-existing cardiovascular conditions may exacerbate COVID-19's impact on heart health.
- Rare cardiovascular adverse events have been reported post-vaccination, requiring further investigation.
Conclusions:
- COVID-19 poses a significant threat to cardiovascular health, necessitating ongoing monitoring and research.
- Understanding the long-term cardiovascular sequelae of infection and vaccination is crucial for patient management.
- Further studies are needed to fully elucidate the relationship between COVID-19, vaccination, and cardiovascular outcomes.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis III: Medical Management
Coronary Artery Disease III: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction

